# EDGAR Filing Document

**Accession Number:** 0000866291
**File Stem:** 0000866291-23-000003
**Filing Date:** 2023-1
**Character Count:** 55496
**Document Hash:** f01a300758281756fe0ff76f4d9b78ae
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000866291-23-000003.hdr.sgml**: 20230131

**ACCESSION NUMBER**: 0000866291-23-000003

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20230131

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230131

**DATE AS OF CHANGE**: 20230131

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ALLEGRO MICROSYSTEMS, INC.
- **CENTRAL INDEX KEY:** 0000866291
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **IRS NUMBER:** 462405937
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39675
- **FILM NUMBER:** 23570240

**BUSINESS ADDRESS:**
- **STREET 1:** 955 PERIMETER ROAD
- **CITY:** MANCHESTER
- **STATE:** NH
- **ZIP:** 03103
- **BUSINESS PHONE:** (603) 626-2300

**MAIL ADDRESS:**
- **STREET 1:** 955 PERIMETER ROAD
- **CITY:** MANCHESTER
- **STATE:** NH
- **ZIP:** 03103

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ALLEGRO MICROSYSTEMS INC
- **DATE OF NAME CHANGE:** 19900730

?xml version="1.0" ? algm-20230131

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

_________________

**FORM 8-K**

**CURRENT REPORT**

_________________

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): January 31, 2023**

**ALLEGRO MICROSYSTEMS, INC.**

**(Exact Name of Registrant as Specified in its Charter)**

_________________

---

| | | | |
|:---|:---|:---|:---|
| **Delaware** | **Delaware** | **001-39675** | **46-2405937** |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **(State or other jurisdiction of**<br>**incorporation or organization)** | **(Commission File Number)** | **(I.R.S. Employer<br>Identification No.)** |
| **955 Perimeter Road** | **955 Perimeter Road** | | |
| **Manchester,** | **New Hampshire** |  | **03103** |
| **(Address of principal executive offices)** | **(Address of principal executive offices)** |  | **(Zip Code)** |

---

**(603) 626-2300**

**(Registrant's telephone number, including area code)**

**N/A**

**(Former Name or Former Address, if Changed Since Last Report)**

_________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

| | | |
|:---|:---|:---|
| Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: |  |
| Title of each class | Trading Symbol | Name of each exchange on which registered |
| Common Stock, par value $0.01 per share | ALGM | The Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02.&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.**

On January 31, 2023, Allegro MicroSystems, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended December 23, 2022. The full text of the press release issued is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

**Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.**

***(d) Exhibits***

---

| | |
|:---|:---|
| Exhibit No. | Description |
| Exhibit 99.1 | <u>[Press Release issued by Allegro MicroSystems, Inc. on January 31, 2023](earningsreleaseq3fy23.htm)</u> |
| Exhibit 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | **ALLEGRO MICROSYSTEMS, INC.** | **ALLEGRO MICROSYSTEMS, INC.** |
| Date: | January 31, 2023 | By: | /s/ Derek P. D'Antilio |
|  |  |  | Derek P. D'Antilio |
|  |  |  | Senior Vice President, Chief Financial Officer and Treasurer |

---

## Exhibit 99.1

**Exhibit 99.1**

**Allegro MicroSystems Reports Fiscal Third Quarter 2023 Results**

***Achieves Record Quarter with Sales Increasing 33% and Earnings Expanding 96% Y-o-Y Led By Continued Strength in E-Mobility***

***Manchester, NH, January 31, 2023 –*** Allegro MicroSystems, Inc. ("Allegro" or the "Company") (Nasdaq:ALGM), a global leader in sensing and power semiconductor solutions for motion control and energy efficient systems, today announced financial results for its third quarter 2023 that ended December 23, 2022.

Quarter Highlights:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Total net sales were a record $248.8 million, increasing 33% year-over-year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Automotive net sales were a record $170.1 million, increasing 30.1% year-over-year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Industrial net sales were a record $51.0 million, increasing 59.9% year-over-year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• GAAP and non-GAAP gross margins were a record 57.3% and 58.0%, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• GAAP and non-GAAP operating margins were a record 26.4% and 30.3%, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• GAAP and non-GAAP diluted earnings per share was $0.33 and $0.35, respectively.

"Our team delivered another quarter of record results. Momentum in e-Mobility applications, including xEV and ADAS, as well as strong demand across our magnetic sensor and power IC product portfolios continues to drive growth," said Vineet Nargolwala, President and CEO of Allegro MicroSystems. "Sales in our Automotive business increased 30 percent year-over-year, with e-Mobility expanding to a record 43 percent of Automotive sales. We also achieved another record quarter in our Industrial business, led by ongoing growth in Clean Energy and Industrial Automation end markets. Complementing our top line performance, fiscal third quarter gross margin expanded to record levels due to higher sales of feature rich products as well as favorable foreign exchange. This allowed us to deliver record GAAP and non-GAAP operating margins of 26 and 30 percent, respectively in the quarter. Further highlighting our operating leverage, GAAP and non-GAAP diluted EPS increased 94 and 84 percent year-over-year, respectively. With Allegro's strategic alignment to fast-growing secular megatrends, we expect to continue to outperform the broader end markets we serve."

**Business Summary**

Automotive net sales increased 8.1% sequentially and 30.1% year-over-year, to 68% of net sales in the quarter. Growth in Automotive sales was driven by strong demand in e-Mobility, including IC solutions for xEV Inverter and On-Board-Charging applications, which expanded to a record 43% of total Automotive sales.

Industrial net sales increased 5.9% sequentially and 59.9% year-over-year to 21% of net sales in the quarter. Record Industrial net sales in the quarter was primarily driven by continued momentum for the Company's solutions in strategic end markets, including Clean Energy and Industrial Automation.

Third quarter net sales into Other markets, which includes computing, consumer and smart home decreased sequentially, however, increased year-over-year to $27.7 million, or 11% of total net sales.

**Outlook**

For the fourth quarter ending March 31, 2023, the Company expects total net sales to be in the range of $260 million to $270 million. Non-GAAP gross margin is expected to be approximately 57.0%, non-GAAP operating expenses are anticipated to be between 27 percent and 28 percent of net sales, and non-GAAP earnings per diluted share are expected to be in the range of $0.35 to $0.37.

*Allegro has not provided a reconciliation of its fourth fiscal quarter outlook for non-GAAP gross margin, non-GAAP operating expenses and non-GAAP earnings per diluted share because estimates of all of the reconciling items cannot be provided without unreasonable efforts. It is difficult to reasonably provide a forward-looking estimate between such forward-looking non-GAAP measures and the comparable forward-looking GAAP measures. Certain factors that are materially significant to Allegro's ability to estimate these items are out of its control and/or cannot be reasonably predicted.*

------

**Earnings Webcast**

A webcast will be held on Tuesday, January 31, 2023 at 8:30 a.m. Eastern time. Vineet Nargolwala, President and Chief Executive Officer, and Derek D'Antilio, Chief Financial Officer, will discuss Allegro's financial results.

The webcast will be available on the Investor Relations section of the Company's website at investors.allegromicro.com. A recording of the webcast will be posted in the same location shortly after the call concludes and will be available for at least 90 days.

**About Allegro MicroSystems**

Allegro MicroSystems is a leading global designer, developer, fabless manufacturer and marketer of sensor integrated circuits ("ICs") and application-specific analog power ICs enabling emerging technologies in the automotive and industrial markets. Allegro's diverse product portfolio provides efficient and reliable solutions for the electrification of vehicles, automotive ADAS safety features, automation for Industry 4.0 and power saving technologies for data centers and green energy applications.

**Forward-Looking Statements**

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding our expected financial performance for our fourth fiscal quarter ending March 31, 2023. In some cases, you can identify forward-looking statements by terms such as "anticipate," "believe," "could," "expect," "should," "plan," "intend," "estimate," "target," "mission," "may," "will," "would," "project," "predict," "contemplate," "potential," or the negative thereof and similar words and expressions.

Forward-looking statements are based on management's current expectations, beliefs and assumptions and on information currently available to us. Such statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various important factors, including, but not limited to: downturns or volatility in general economic conditions, including as a result of the COVID-19 pandemic, particularly in the automotive market; our ability to compete effectively, expand our market share and increase our net sales and profitability; our reliance on a limited number of third-party wafer fabrication facilities and suppliers of other materials; our failure to adjust purchase commitments, supply chain volume and inventory management based on changing market conditions or customer demand; shifts in our product mix or customer mix, which could negatively impact our gross margin; the cyclical nature of the analog semiconductor industry; our ability to compensate for decreases in average selling prices of our products and increases in input costs; increases in inflation rates or sustained periods of inflation in the markets in which we operate; any disruptions at our primary third-party wafer fabrication facilities; our ability to manage any sustained yield problems or other delays at our third-party wafer fabrication facilities or in the final assembly and test of our products; our ability to fully realize the benefits of past and potential future initiatives designed to improve our competitiveness, growth and profitability; our ability to accurately predict our quarterly net sales and operating results; our dependence on manufacturing operations in the Philippines; our reliance on distributors to generate sales; COVID-19 induced lock-downs and suppression on our supply chain and customer demand; our ability to develop new product features or new products in a timely and cost-effective manner; our ability to manage growth; any slowdown in the growth of our end markets; the loss of one or more significant customers; our ability to meet customers' quality requirements; uncertainties related to the design win process and our ability to recover design and development expenses and to generate timely or sufficient net sales or margins; changes in government trade policies, including the imposition of tariffs and export restrictions; our exposures to warranty claims, product liability claims and product recalls; our dependence on international customers and operations; the availability of rebates, tax credits and other financial incentives on end-user demands for certain products; risks related to governmental regulation and other legal obligations, including privacy, data protection, information security, consumer protection, environmental and occupational health and safety, anti-corruption and anti-bribery, and trade controls; the volatility of currency exchange rates; our indebtedness may limit our flexibility to operate our business; our ability to retain key and highly skilled personnel; our ability to protect our proprietary technology and inventions through patents or trade secrets; our ability to commercialize our products without infringing third-party intellectual property rights; disruptions or breaches of our information technology systems or those of our third-party service providers; our principal stockholders have substantial control over us; the inapplicability of the "corporate opportunity" doctrine to any director or stockholder who is not employed by us; the dilutive impact on the price of our shares upon future

------

issuance by us or future sales by our stockholders; our lack of intent to declare or pay dividends for the foreseeable future; anti-takeover provisions in our organizational documents and under the General Corporation Law of the State of Delaware; the exclusive forum provision in our Certificate of Incorporation for disputes with stockholders; our inability to design, implement or maintain effective internal control over financial reporting; changes in tax rates or the adoption of new tax legislation; and other important factors discussed under the caption "Risk Factors" in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on May 18, 2022, as amended by Amendment No. 1 on Form 10-K/A filed with the SEC on August 29, 2022, as any such factors may be updated from time to time in our other filings with the SEC, which are accessible on the SEC's website at *www.sec.gov* and the Investors Relations page of our website at *investors.allegromicro.com*.

**ALLEGRO MICROSYSTEMS, INC.<br>CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS**

**(in thousands, except share and per share amounts)**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three-Month Period Ended** | **Three-Month Period Ended** | **Nine-Month Period Ended** | **Nine-Month Period Ended** |
| | **December 23,<br>2022** | **December 24,<br>2021** | **December 23,<br>2022** | **December 24,<br>2021** |
| Net sales | $203672 | $147168 | $572356 | $456302 |
| Net sales to related party | 45117 | 39461 | 131852 | 112079 |
| Total net sales | 248789 | 186629 | 704208 | 568381 |
| Cost of goods sold | 84776 | 66675 | 247805 | 214811 |
| Cost of goods sold to related party | 21419 | 18789 | 63413 | 55713 |
| Gross profit | 142594 | 101165 | 392990 | 297857 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 39593 | 30297 | 109017 | 89441 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 37373 | 37963 | 146470 | 104115 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration |  | (2700) | (2700) | (2100) |
| Total operating expenses | 76966 | 65560 | 252787 | 191456 |
| Operating income | 65628 | 35605 | 140203 | 106401 |
| Other income (expense): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (613) | (427) | (1581) | (2081) |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | 360 | 158 | 1144 | 317 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency transaction gain (loss) | 407 | (3) | 2597 | (55) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income in earnings of equity investment | 2190 | 287 | 297 | 792 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | 4119 | 3634 | 765 | 5216 |
| Income before income taxes | 72091 | 39254 | 143425 | 110590 |
| Income tax provision | 7540 | 6281 | 17943 | 16687 |
| Net income | 64551 | 32973 | 125482 | 93903 |
| Net income attributable to non-controlling interests | 32 | 37 | 102 | 112 |
| Net income attributable to Allegro MicroSystems, Inc. | $64519 | $32936 | $125380 | $93791 |
| Net income attributable to Allegro MicroSystems, Inc. per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.34 | $0.17 | $0.66 | $0.49 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.33 | $0.17 | $0.65 | $0.49 |
| Weighted average shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 191328538 | 189736901 | 191082141 | 189665324 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 193935908 | 192068222 | 193100762 | 191678951 |

---

------

**Supplemental Schedule of Total Net Sales**

The following table summarizes total net sales by market within the Company's unaudited consolidated statements of operations:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three-Month Period Ended** | **Three-Month Period Ended** | **Change** | **Change** | **Nine-Month Period Ended** | **Nine-Month Period Ended** | **Change** | **Change** |
| | **December 23,<br>2022** | **December 24,<br>2021** | **Amount** | **%** | **December 23,<br>2022** | **December 24,<br>2021** | **Amount** | **%** |
| | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| Automotive | $170107 | $130797 | $39310 | 30.1% | $477154 | $390351 | $86803 | 22.2% |
| Industrial | 51014 | 31903 | 19111 | 59.9% | 139330 | 98533 | 40797 | 41.4% |
| Other | 27668 | 23929 | 3739 | 15.6% | 87724 | 79497 | 8227 | 10.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net sales | $248789 | $186629 | $62160 | 33.3% | $704208 | $568381 | $135827 | 23.9% |

---

**Supplemental Schedule of Stock-Based Compensation**

The Company recorded stock-based compensation expense in the following expense categories of its unaudited consolidated statements of operations:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three-Month Period Ended** | **Three-Month Period Ended** | **Nine-Month Period Ended** | **Nine-Month Period Ended** |
| (In thousands) | **December 23,<br>2022** | **December 24,<br>2021** | **December 23,<br>2022** | **December 24,<br>2021** |
| Cost of sales | $1156 | $742 | $3112 | $1992 |
| Research and development | 3174 | 1019 | 6013 | 2814 |
| Selling, general and administrative | 4572 | 5859 | 42117 | 13841 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total stock-based compensation** | $8902 | $7620 | $51242 | $18647 |

---

**Supplemental Schedule of Acquisition Related Intangible Amortization Costs**

The Company recorded intangible amortization expense related to its acquisitions of Heyday and Voxtel in the following expense categories of its unaudited consolidated statements of operations:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three-Month Period Ended** | **Three-Month Period Ended** | **Nine-Month Period Ended** | **Nine-Month Period Ended** |
| (In thousands) | **December 23,<br>2022** | **December 24,<br>2021** | **December 23,<br>2022** | **December 24,<br>2021** |
| Cost of sales | $589 | $273 | 1240 | 819 |
| Selling, general and administrative | 23 | 23 | 68 | 68 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total intangible amortization** | $612 | $296 | $1308 | $887 |

---

------

**ALLEGRO MICROSYSTEMS, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(in thousands, except share and per share amounts)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **December 23,<br>2022** | **March 25,<br>2022** |
| **Assets** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $334306 | $282383 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 9822 | 7416 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade accounts receivable, net of provision for expected credit losses of $147 and $105 at December 23, 2022 and March 25, 2022, respectively | 97225 | 87359 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade and other accounts receivable due from related party | 31070 | 27360 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable – other | 2169 | 4144 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 119580 | 86160 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 22030 | 14995 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of related party note receivable | 3750 | 1875 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 619952 | 511692 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment, net | 232076 | 210028 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 14740 | 16049 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax assets | 46262 | 17967 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 28230 | 20009 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible assets, net | 53130 | 35970 |
| &nbsp;&nbsp;&nbsp;&nbsp;Related party note receivable, less current portion | 9375 | 5625 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity investment in related party | 27968 | 27671 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 52332 | 47609 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $1084065 | $892620 |
| **Liabilities, Non-Controlling Interest and Stockholders' Equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade accounts payable | $49945 | $29836 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts due to related party | 5659 | 5222 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | 77796 | 65459 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of operating lease liabilities | 3828 | 3706 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 137228 | 104223 |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligations due under Senior Secured Credit Facilities | 25000 | 25000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities, less current portion | 11358 | 12748 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax liabilities | 4438 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other long-term liabilities | 11485 | 15286 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 189509 | 157257 |
| Commitments and contingencies |  |  |
| Stockholders' Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred Stock, $0.01 par value; 20,000,000 shares authorized, no shares issued or outstanding at December 23, 2022 and March 25, 2022 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.01 par value; 1,000,000,000 shares authorized, 191,435,869 shares issued and outstanding at December 23, 2022; 1,000,000,000 shares authorized, 190,473,595 issued and outstanding at March 25, 2022 | 1914 | 1905 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 667908 | 627792 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 248338 | 122958 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (24781) | (18448) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity attributable to Allegro MicroSystems, Inc. | 893379 | 734207 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-controlling interests | 1177 | 1156 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 894556 | 735363 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities, non-controlling interest and stockholders' equity | $1084065 | $892620 |

---

------

**ALLEGRO MICROSYSTEMS, INC.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(in thousands)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Nine-Month Period Ended** | **Nine-Month Period Ended** |
| | **December 23,<br>2022** | **December 24,<br>2021** |
| **CASH FLOWS FROM OPERATING ACTIVITIES:** | | |
| Net income | $125482 | $93903 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 36705 | 36522 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of deferred financing costs | 74 | 75 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | (28387) | (3061) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 51242 | 18647 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss (gain) on disposal of assets | 287 | (349) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | (2700) | (2100) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provisions for inventory and receivables reserves | 1744 | 4787 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized loss (gain) on marketable securities | 5 | (4482) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts receivable | (5894) | (6133) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable - other | 2000 | (9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (39136) | 3251 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | (17761) | (11870) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts payable | 19553 | 2026 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Due to/from related parties | (3273) | (2775) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current and long-term liabilities | 5717 | (9874) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 145658 | 118558 |
| **CASH FLOWS FROM INVESTING ACTIVITIES:** |  |  |
| Purchases of property, plant and equipment | (49563) | (55792) |
| Acquisition of business, net of cash acquired | (19728) | (12549) |
| Proceeds from sales of property, plant and equipment |  | 27407 |
| Investments in marketable securities |  | (9189) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (69291) | (50123) |
| **CASH FLOWS FROM FINANCING ACTIVITIES:** |  |  |
| Loans made to related party | (7500) | (7500) |
| Receipts on related party notes receivable | 1875 |  |
| Payments for taxes related to net share settlement of equity awards | (12642) |  |
| Proceeds from issuance of common stock under employee stock purchase plan | 1573 | 1291 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | (16694) | (6209) |
| Effect of exchange rate changes on Cash and cash equivalents and Restricted cash | (5344) | 604 |
| Net increase in Cash and cash equivalents and Restricted cash | 54329 | 62830 |
| Cash and cash equivalents and Restricted cash at beginning of period | 289799 | 203875 |
| **CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD:** | $344128 | $266705 |
| **RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents at beginning of period | $282383 | $197214 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted cash at beginning of period | 7416 | 6661 |
| Cash and cash equivalents and Restricted cash at beginning of period | $289799 | $203875 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents at end of period | 334306 | 259208 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted cash at end of period | 9822 | 7497 |
| Cash and cash equivalents and Restricted cash at end of period | $344128 | $266705 |
| **SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:** |  |  |
| Noncash transactions: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment purchases included in trade accounts payable | $(2462) | $(4934) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Noncash lease liabilities arising from obtaining right-of-use assets | 1926 | 1906 |

---

------

**Non-GAAP Financial Measures**

In addition to the measures presented in our consolidated financial statements, we regularly review other measures, defined as non-GAAP financial measures by the SEC, to evaluate our business, measure our performance, identify trends, prepare financial forecasts and make strategic decisions. The key measures we consider are non-GAAP Gross Profit, non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Operating Income, non-GAAP Operating Margin, non-GAAP Profit before Tax, non-GAAP Provision for Income Tax, non-GAAP Net Income, non-GAAP Net Income per Share, EBITDA, Adjusted EBITDA and Adjusted EBITDA margin (collectively, the "Non-GAAP Financial Measures"). These Non-GAAP Financial Measures provide supplemental information regarding our operating performance on a non-GAAP basis that excludes certain gains, losses and charges of a non-cash nature or that occur relatively infrequently and/or that management considers to be unrelated to our core operations, and in the case of non-GAAP Provision for Income Tax, management believes that this non-GAAP measure of income taxes provides it with the ability to evaluate the non-GAAP Provision for Income Taxes across different reporting periods on a consistent basis, independent of special items and discrete items, which may vary in size and frequency. By presenting these Non-GAAP Financial Measures, we provide a basis for comparison of our business operations between periods by excluding items that we do not believe are indicative of our core operating performance, and we believe that investors' understanding of our performance is enhanced by our presenting these Non-GAAP Financial Measures, as they provide a reasonable basis for comparing our ongoing results of operations. Management believes that tracking and presenting these Non-GAAP Financial Measures provides management and the investment community with valuable insight into matters such as: our ongoing core operations, our ability to generate cash to service our debt and fund our operations; and the underlying business trends that are affecting our performance. These Non-GAAP Financial Measures are used by both management and our board of directors, together with the comparable GAAP information, in evaluating our current performance and planning our future business activities. In particular, management finds it useful to exclude non-cash charges in order to better correlate our operating activities with our ability to generate cash from operations and to exclude certain cash charges as a means of more accurately predicting our liquidity requirements. We believe that these Non-GAAP Financial Measures, when used in conjunction with our GAAP financial information, also allow investors to better evaluate our financial performance in comparison to other periods and to other companies in our industry.

These Non-GAAP Financial Measures have significant limitations as analytical tools. Some of these limitations are that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• such measures do not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• such measures exclude certain costs which are important in analyzing our GAAP results;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• such measures do not reflect changes in, or cash requirements for, our working capital needs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• such measures do not reflect the interest expense, or the cash requirements necessary to service interest or principal payments on our debt;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• such measures do not reflect our tax expense or the cash requirements to pay our taxes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• certain measures do not reflect any cash requirements for such replacements; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• other companies in our industry may calculate such measures differently than we do, thereby further limiting their usefulness as comparative measures.

The Non-GAAP Financial Measures are supplemental measures of our performance that are neither required by, nor presented in accordance with, GAAP. These Non-GAAP Financial Measures should not be considered as substitutes for GAAP financial measures such as gross profit, gross margin, net income or any other performance measures derived in accordance with GAAP. Also, in the future we may incur expenses or charges such as those being adjusted in the calculation of these Non-GAAP Financial Measures. Our presentation of these Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items.

------

***Non-GAAP Gross Profit and Non-GAAP Gross Margin***

We calculate non-GAAP Gross Profit and non-GAAP Gross Margin excluding the items below from cost of goods sold in applicable periods, and we calculate non-GAAP Gross Margin as non-GAAP Gross Profit divided by total net sales.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Voxtel inventory impairment—Represents costs related to the discontinuation of one of our product lines manufactured by Voxtel.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Stock-based compensation—Represents non-cash expenses arising from the grant of stock-based awards. A significant portion of the cost included in fiscal year 2023 related to retirement of the former CEO.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• AMTC Facility consolidation one-time costs—Represents one-time costs incurred in connection with closing of the AMTC Facility and transitioning of test and assembly functions to the AMPI Facility announced in fiscal year 2020, consisting of: moving equipment between facilities, contract terminations and other non-recurring charges. The closure and transition of the AMTC Facility was substantially completed as of the end of March 2021, and we sold the AMTC Facility in August 2021.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Amortization of acquisition-related intangible assets—Represents non-cash expenses associated with the amortization of intangible assets in connection with the acquisition of Voxtel, which closed in August 2020 and Heyday Integrated Circuits ("Heyday"), which closed in September 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• COVID-19 related expenses—Represents expenses attributable to the COVID-19 pandemic primarily related to increased purchases of masks, gloves and other protective materials, and overtime premium compensation paid for maintaining 24-hour service at the AMPI Facility through fiscal year 2022.

***Non-GAAP Operating Expenses, non-GAAP Operating Income and non-GAAP Operating Margin***

We calculate non-GAAP Operating Expenses and non-GAAP Operating Income excluding the same items excluded above to the extent they are classified as operating expenses, and also excluding the items below in applicable periods. We calculate non-GAAP Operating Margin as non-GAAP Operating Income divided by total net sales.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Transaction fees—Represents (i) one-time transaction-related legal, consulting and registration fees related to a secondary offering on behalf of certain stockholders in fiscal 2022, (ii) one-time transaction-related legal and consulting fees in fiscal 2023 and 2022 not related to (i), and (iii) the acquisition of Heyday.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Severance—Represents severance costs associated with (i) the closing of the AMTC Facility and the transitioning of test and assembly functions to the AMPI Facility announced and initiated in fiscal year 2020, (ii) costs related to the discontinuation of one of our product lines manufactured by Voxtel in fiscal year 2022, and (iii) nonrecurring separation costs related to the departures of executive officers in fiscal years 2023 and 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Change in fair value of contingent consideration—Represents the change in fair value of contingent consideration payable in connection with the acquisition of Voxtel.

***EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin***

We calculate EBITDA as net income minus interest income (expense), tax provision (benefit), and depreciation and amortization expenses. We calculate Adjusted EBITDA as EBITDA excluding the same items excluded above and also excluding the items below in applicable periods. We calculate Adjusted EBITDA Margin as Adjusted EBITDA divided by total net sales.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-core loss (gain) on sale of equipment—Represents non-core miscellaneous losses and gains on the sale of equipment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Foreign currency translation (gain) loss—Represents losses and gains resulting from the remeasurement and settlement of intercompany debt and operational transactions, as well as transactions with external customers or vendors denominated in currencies other than the functional currency of the legal entity in which the transaction is recorded.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• (Income) loss in earnings of equity investment—Represents our equity method investment in Polar Semiconductor, LLC ("PSL").

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Unrealized (gain) loss on investments—Represents mark-to-market adjustments on equity investments with readily determinable fair values.

***Non-GAAP Profit before Tax, Non-GAAP Net Income, and Non-GAAP Basic and Diluted Earnings Per Share***

We calculate non-GAAP Profit before Tax as Income before Income Taxes excluding the same items excluded above in applicable periods. We calculate non-GAAP Net Income as Net Income excluding the same items excluded above in applicable periods.

***Non-GAAP Provision for Income Tax***

In calculating non-GAAP Provision for Income Tax, we have added back the following to GAAP Income Tax Provision:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Tax effect of adjustments to GAAP results—Represents the estimated income tax effect of the adjustments to non-GAAP Profit Before Tax described above and elimination of discrete tax adjustments.

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three-Month Period Ended** | **Three-Month Period Ended** | **Three-Month Period Ended** | **Three-Month Period Ended** | **Three-Month Period Ended** | **Three-Month Period Ended** | **Nine-Month Period Ended** | **Nine-Month Period Ended** | **Nine-Month Period Ended** | **Nine-Month Period Ended** |
| | **December 23,<br>2022** | **December 23,<br>2022** | **September 23,<br>2022** | **September 23,<br>2022** | **December 24,<br>2021** | **December 24,<br>2021** | **December 23,<br>2022** | **December 23,<br>2022** | **December 24,<br>2021** | **December 24,<br>2021** |
| | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| ***Reconciliation of Non-GAAP Gross Profit*** | | | | | | | | | | |
| **GAAP Gross Profit** | **$** | **142594** | **$** | **132022** | **$** | **101165** | **$** | **392990** | **$** | **297857** |
| &nbsp;&nbsp;Voxtel inventory impairment |  |  |  |  |  |  |  |  | 3106 | 3106 |
| &nbsp;&nbsp;Stock-based compensation | 1156 | 1156 | 1124 | 1124 | 742 | 742 | 3112 | 3112 | 1992 | 1992 |
| &nbsp;&nbsp;AMTC Facility consolidation one-time costs |  |  |  |  |  |  |  |  | 144 | 144 |
| &nbsp;&nbsp;Amortization of acquisition-related intangible assets | 589 | 589 | 378 | 378 | 273 | 273 | 1240 | 1240 | 819 | 819 |
| &nbsp;&nbsp;COVID-19 related expenses |  |  |  |  | 137 | 137 |  |  | 796 | 796 |
| **Total Non-GAAP Adjustments** | **$** | **1745** | **$** | **1502** | **$** | **1152** | **$** | **4352** | **$** | **6857** |
| **Non-GAAP Gross Profit** | **$** | **144339** | **$** | **133524** | **$** | **102317** | **$** | **397342** | **$** | **304714** |
| **Non-GAAP Gross Margin** | **58.0%** | **58.0%** | **56.2%** | **56.2%** | **54.8%** | **54.8%** | **56.4%** | **56.4%** | **53.6%** | **53.6%** |

---

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three-Month Period Ended** | **Three-Month Period Ended** | **Three-Month Period Ended** | **Nine-Month Period Ended** | **Nine-Month Period Ended** |
| | **December 23,<br>2022** | **September 23,<br>2022** | **December 24,<br>2021** | **December 23,<br>2022** | **December 24,<br>2021** |
| | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| ***Reconciliation of Non-GAAP Operating Expenses*** | | | | | |
| **GAAP Operating Expenses** | $**76966** | $**72184** | $**65560** | $**252787** | $**191456** |
| **Research and Development Expenses** |  |  |  |  |  |
| GAAP Research and Development Expenses | 39593 | 35567 | 30297 | 109017 | 89441 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 3174 | 1711 | 1019 | 6013 | 2814 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AMTC Facility consolidation one-time costs |  |  |  |  | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;COVID-19 related expenses |  |  | 6 |  | 20 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction fees | 1 | 201 |  | 404 |  |
| Non-GAAP Research and Development Expenses | 36418 | 33655 | 29272 | 102600 | 86605 |
| **Selling, General and Administrative Expenses** |  |  |  |  |  |
| GAAP Selling, General and Administrative Expenses | 37373 | 39117 | 37963 | 146470 | 104115 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 4572 | 5369 | 5859 | 42117 | 13841 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AMTC Facility consolidation one-time costs | 291 | 90 | 108 | 477 | 583 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of acquisition-related intangible assets | 23 | 23 | 23 | 68 | 68 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;COVID-19 related expenses |  |  | 356 |  | 1288 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction fees | 35 | 63 | 1085 | 1695 | 1114 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Severance |  |  | 578 | 4186 | 746 |
| Non-GAAP Selling, General and Administrative Expenses | 32452 | 33572 | 29954 | 97927 | 86475 |
| Change in fair value of contingent consideration |  | (2500) | (2700) | (2700) | (2100) |
| **Total Non-GAAP Adjustments** | **8096** | **4957** | **6334** | **52260** | **18376** |
| **Non-GAAP Operating Expenses** | $**68870** | $**67227** | $**59226** | $**200527** | $**173080** |

---

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three-Month Period Ended** | **Three-Month Period Ended** | **Three-Month Period Ended** | **Three-Month Period Ended** | **Three-Month Period Ended** | **Nine-Month Period Ended** | **Nine-Month Period Ended** | **Nine-Month Period Ended** |
| | **December 23,<br>2022** | **December 23,<br>2022** | **September 23,<br>2022** | **September 23,<br>2022** | **December 24,<br>2021** | **December 23,<br>2022** | **December 23,<br>2022** | **December 24,<br>2021** |
| | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| ***Reconciliation of Non-GAAP Operating Income*** | | | | | | | | |
| **GAAP Operating Income** | **$** | **65628** | **$** | **59838** | **35605** | **$** | **140203** | **106401** |
| &nbsp;&nbsp;Voxtel inventory impairment |  |  |  |  |  |  |  | 3106 |
| &nbsp;&nbsp;Stock-based compensation | 8902 | 8902 | 8204 | 8204 | 7620 | 51242 | 51242 | 18647 |
| &nbsp;&nbsp;AMTC Facility consolidation one-time costs | 291 | 291 | 90 | 90 | 108 | 477 | 477 | 729 |
| &nbsp;&nbsp;Amortization of acquisition-related intangible assets | 612 | 612 | 401 | 401 | 296 | 1308 | 1308 | 887 |
| &nbsp;&nbsp;COVID-19 related expenses |  |  |  |  | 499 |  |  | 2104 |
| &nbsp;&nbsp;Change in fair value of contingent consideration |  |  | (2500) | (2500) | (2700) | (2700) | (2700) | (2100) |
| &nbsp;&nbsp;Transaction fees | 36 | 36 | 264 | 264 | 1085 | 2099 | 2099 | 1114 |
| &nbsp;&nbsp;Severance |  |  |  |  | 578 | 4186 | 4186 | 746 |
| **Total Non-GAAP Adjustments** | **$** | **9841** | **$** | **6459** | **7486** | **$** | **56612** | **25233** |
| **Non-GAAP Operating Income** | **$** | **75469** | **$** | **66297** | **43091** | **$** | **196815** | **131634** |
| **Non-GAAP Operating Margin (% of net sales)** | **30.3%** | **30.3%** | **27.9%** | **27.9%** | **23.1%** | **27.9%** | **27.9%** | **23.2%** |

---

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three-Month Period Ended** | **Three-Month Period Ended** | **Three-Month Period Ended** | **Nine-Month Period Ended** | **Nine-Month Period Ended** |
| | **December 23,<br>2022** | **September 23,<br>2022** | **December 24,<br>2021** | **December 23,<br>2022** | **December 24,<br>2021** |
| | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| ***Reconciliation of EBITDA and Adjusted EBITDA*** | | | | | |
| **GAAP Net Income** | **64551** | **50648** | **32973** | **125482** | **93903** |
| &nbsp;&nbsp;Interest expense | 613 | 531 | 427 | 1581 | 2081 |
| &nbsp;&nbsp;Interest income | (360) | (467) | (158) | (1144) | (317) |
| &nbsp;&nbsp;Income tax provision | 7540 | 8438 | 6281 | 17943 | 16687 |
| &nbsp;&nbsp;Depreciation & amortization | 12580 | 12207 | 12011 | 36705 | 36522 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**EBITDA** | **84924** | **71357** | **51534** | **180567** | **148876** |
| &nbsp;&nbsp;Non-core loss (gain) on sale of equipment | 37 | 253 | (19) | 287 | (350) |
| &nbsp;&nbsp;Voxtel inventory impairment |  |  |  |  | 3106 |
| &nbsp;&nbsp;Foreign currency translation (gain) loss | (407) | (266) | 3 | (2597) | 55 |
| &nbsp;&nbsp;(Income) loss in earnings of equity investment | (2190) | 1029 | (287) | (297) | (792) |
| &nbsp;&nbsp;Unrealized (gain) loss on investments | (3453) | (28) | (3504) | 5 | (4482) |
| &nbsp;&nbsp;Stock-based compensation | 8902 | 8204 | 7620 | 51242 | 18647 |
| &nbsp;&nbsp;AMTC Facility consolidation one-time costs | 291 | 90 | 108 | 477 | 729 |
| &nbsp;&nbsp;COVID-19 related expenses |  |  | 499 |  | 2104 |
| &nbsp;&nbsp;Change in fair value of contingent consideration |  | (2500) | (2700) | (2700) | (2100) |
| &nbsp;&nbsp;Transaction fees | 36 | 264 | 1085 | 2099 | 1114 |
| &nbsp;&nbsp;Severance |  |  | 578 | 4186 | 746 |
| **Adjusted EBITDA** | **88140** | **78403** | **54917** | **233269** | **167653** |
| **Adjusted EBITDA Margin (% of net sales)** | **35.4%** | **33.0%** | **29.4%** | **33.1%** | **29.5%** |

---

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three-Month Period Ended** | **Three-Month Period Ended** | **Three-Month Period Ended** | **Nine-Month Period Ended** | **Nine-Month Period Ended** |
| | **December 23,<br>2022** | **September 23,<br>2022** | **December 24,<br>2021** | **December 23,<br>2022** | **December 24,<br>2021** |
| | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| ***Reconciliation of Non-GAAP Profit before Tax*** | | | | | |
| **GAAP Income before Income Taxes** | $**72091** | $**59086** | $**39254** | $**143425** | $**110590** |
| &nbsp;&nbsp;Non-core loss (gain) on sale of equipment | 37 | 253 | (19) | 287 | (350) |
| &nbsp;&nbsp;Voxtel inventory impairment |  |  |  |  | 3106 |
| &nbsp;&nbsp;Foreign currency translation (gain) loss | $(407) | $(266) | $3 | $(2597) | $55 |
| &nbsp;&nbsp;(Income) loss in earnings of equity investment | $(2190) | $1029 | $(287) | $(297) | $(792) |
| &nbsp;&nbsp;Unrealized (gain) loss on investments | $(3453) | $(28) | $(3504) | $5 | $(4482) |
| &nbsp;&nbsp;Stock-based compensation | 8902 | 8204 | 7620 | 51242 | 18647 |
| &nbsp;&nbsp;AMTC Facility consolidation one-time costs | 291 | 90 | 108 | 477 | 729 |
| &nbsp;&nbsp;Amortization of acquisition-related intangible assets | 612 | 401 | 296 | 1308 | 887 |
| &nbsp;&nbsp;COVID-19 related expenses |  |  | 499 |  | 2104 |
| &nbsp;&nbsp;Change in fair value of contingent consideration |  | (2500) | (2700) | (2700) | (2100) |
| &nbsp;&nbsp;Transaction fees | 36 | 264 | 1085 | 2099 | 1114 |
| &nbsp;&nbsp;Severance |  |  | 578 | 4186 | 746 |
| **Total Non-GAAP Adjustments** | $**3828** | $**7447** | $**3679** | $**54010** | $**19664** |
| **Non-GAAP Profit before Tax** | $**75919** | $**66533** | $**42933** | $**197435** | $**130254** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three-Month Period Ended** | **Three-Month Period Ended** | **Three-Month Period Ended** | **Nine-Month Period Ended** | **Nine-Month Period Ended** |
| | **December 23,<br>2022** | **September 23,<br>2022** | **December 24,<br>2021** | **December 23,<br>2022** | **December 24,<br>2021** |
| | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
|  ***Reconciliation of Non-GAAP Provision for Income Taxes*** | | | | | |
| **GAAP Income Tax Provision** | $**7540** | $**8438** | $**6281** | $**17943** | $**16687** |
| &nbsp;&nbsp;GAAP effective tax rate | 10.5% | 14.3% | 16.0% | 12.5% | 15.1% |
| &nbsp;&nbsp;Tax effect of adjustments to GAAP results | (461) | (1663) | 561 | 3776 | 3598 |
| **Non-GAAP Provision for Income Taxes** | $**7079** | $**6775** | $**6842** | $**21719** | $**20285** |
| *Non-GAAP effective tax rate* | 9.3% | 10.2% | 15.9% | 11.0% | 15.6% |

---

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three-Month Period Ended** | **Three-Month Period Ended** | **Three-Month Period Ended** | **Nine-Month Period Ended** | **Nine-Month Period Ended** |
| | **December 23,<br>2022** | **September 23,<br>2022** | **December 24,<br>2021** | **December 23,<br>2022** | **December 24,<br>2021** |
| | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
|<br><br>***Reconciliation of Non-GAAP Net Income***<br>**GAAP Net Income** | $**64551** | $**50648** | $**32973** | $**125482** | $**93903** |
| **GAAP Basic Earnings per Share** | $0.34 | $0.26 | $0.17 | $0.66 | $0.50 |
| **GAAP Diluted Earnings per Share** | $0.33 | $0.26 | $0.17 | $0.65 | $0.49 |
| &nbsp;&nbsp;Non-core loss (gain) on sale of equipment | 37 | 253 | (19) | 287 | (350) |
| &nbsp;&nbsp;Voxtel inventory impairment |  |  |  |  | 3106 |
| &nbsp;&nbsp;Foreign currency translation (gain) loss | (407) | (266) | 3 | (2597) | 55 |
| &nbsp;&nbsp;Loss (income) in earnings of equity investment | (2190) | 1029 | (287) | (297) | (792) |
| &nbsp;&nbsp;Unrealized (gain) loss on investments | (3453) | (28) | (3504) | 5 | (4482) |
| &nbsp;&nbsp;Stock-based compensation | 8902 | 8204 | 7620 | 51242 | 18647 |
| &nbsp;&nbsp;AMTC Facility consolidation one-time costs | 291 | 90 | 108 | 477 | 729 |
| &nbsp;&nbsp;Amortization of acquisition-related intangible assets | 612 | 401 | 296 | 1308 | 887 |
| &nbsp;&nbsp;COVID-19 related expenses |  |  | 499 |  | 2104 |
| &nbsp;&nbsp;Change in fair value of contingent consideration |  | (2500) | (2700) | (2700) | (2100) |
| &nbsp;&nbsp;Transaction fees | 36 | 264 | 1085 | 2099 | 1114 |
| &nbsp;&nbsp;Severance |  |  | 578 | 4186 | 746 |
| &nbsp;&nbsp;Tax effect of adjustments to GAAP results | 461 | 1663 | (561) | (3776) | (3598) |
| **Non-GAAP Net Income** | $**68840** | $**59758** | $**36091** | $**175716** | $**109969** |
| Basic weighted average common shares | 191328538 | 191284631 | 189736901 | 191082141 | 189665324 |
| Diluted weighted average common shares | 193935908 | 192639576 | 192068222 | 193100762 | 191678951 |
| **Non-GAAP Basic Earnings per Share** | $0.36 | $0.31 | $0.19 | $0.92 | $0.58 |
| **Non-GAAP Diluted Earnings per Share** | $0.35 | $0.31 | $0.19 | $0.91 | $0.57 |

---

**Investor Contact:**

Jalene Hoover

VP of Investor Relations & Corporate Communications

+1 (512) 751-6526

jhoover@allegromicro.com

<br>